<p>I try very hard to not have bad days, or even bad moments out of this, but sometimes it’s just simply impossible. It’s no wonder the mortality rate for serious diseases is not lower; the stress of working with the information is simply overwhelming. I have not yet transferred care to Washington because they need to give me a treatment plan first; they cannot do so until they see comparative scans; I cannot (yet) provide comparative scans because the originating hospital lost them, and, the records department has a two week backlog to even be able to pull the pathology report. So, I am in the position of moving to D.C. but holding medical care in Miami - which sort of works, because I do like my local oncologist. </p>
<p>But Lombardi is sort of troubling to me at this point anyway (lack of responsiveness, and, when I asked for copies of my films, they did give them to me, but, they ended up being some other patient’s films). </p>
<p>So as backup, I am in the process of scheduling December and January appointments with Johns Hopkins and Sloan Kettering, respectively. </p>
<p>JEM, Northeastmom, I know you are trying to help, and I certainly don’t want to be negative or alienate support and people who mean well, but, this particular disease is so frustrating. Websites like Yale’s do not really tell the tale, as I understand it. </p>
<p>Small cell has an excellent response rate to chemotherapy and radiation - it’s really easy to kill, the first time. Then, it recurrs, very resistant and nearly impossible to kill - in 95% of persons. Then, there is a second line chemotherapy, which works in only 20% of persons. Then, there is nothing, except clinical trials. No third line. I was on the phone this morning with a trial researcher; we found two that I might qualify for if I need them (we are trying to work this as a “worst case scenario” position) - anyway, one is in California, the other in Cleveland. But they are phase I and II trials, and, I see nothing in the pipeline for phase III trials with curative intent, and, unlike other cancers and illnesses, I see nothing in the new drug pipeline, either. Bottom line, no one is working on this. Or, they are working very hard on it, and cannot come up with anything that works against small cell. It appears to be very discouraging for researchers, etc. </p>
<p>Even Johns Hopkins admiited this morning “yep, pretty much everyone dies after the recurrance” - I told them, gee, I really wish you would have said just about anything but that.</p>
<p>Of course, it doesn’t mean that it is hopeless - the goal is to get to a remission position, and try to stay there. Then, the longer one stays in remisssion, the better the odds, however, it’s equally critical to make sure to find a physician that supports a very aggressive treatment plan. In the long term survivors I have spoken to, they all appear to have been in the care of doctors who pushed the envelope in terms of treatment.</p>